With JALM, the Association for Diagnostics & Laboratory Medicine (ADLM) empowers lab professionals to discover new adaptive solutions to patient health problems and drive innovation in the field. JALM expands on the scope of cutting-edge research in Clinical Chemistry by focusing on translational or applied laboratory medicine studies.
JALM considers submissions on laboratory methods and practice, evidence-based laboratory medicine and related clinical topics, clinical chemistry (including toxicology and therapeutic drug monitoring), and more. Additionally, it provides a forum for discussion of policy and regulatory issues that impact the field.
JALM is a fully open access journal. Visit the open access page for details. ADLM Professional members who are the corresponding author of a paper accepted by JALM receive a discount on open access fees as a member benefit.
ADLM releases first-of-its-kind U.S. guidance for laboratory professionals.
Researchers developed an approach using for safe and effective screening of patients with possible acute myocardial infarction.
Listen to podcast episodes from experts in the field, keeping you up to date with the latest research on all areas of laboratory medicine.
Reported interindividual variation in eGFR performance is significantly larger than any potential benefit derived from race coefficients.
Learn more about advertising opportunities in JALM.
